about
Pharmacokinetics of repeated sodium salicylate administration to laying hens: evidence for time dependent increase in drug elimination from plasma and eggsAtypical calcium coordination number: Physicochemical study, cytotoxicity, DFT calculations and in silico pharmacokinetic characteristics of calcium caffeates.Application of ultra-performance columns in high-performance liquid chromatography for determination of albendazole and its metabolites in turkeys.Method of variability optimization in pharmacokinetic data analysis.The effect of sunitinib on the plasma exposure of intravenous paracetamol and its major metabolite: paracetamol glucuronide.The using of a piglets as a model for evaluating the dipyrone hematological effects.Harmonization of rules in GLP and pharmacokinetic analysis: regulatory view.Fentanyl with ropivacaine infusion for postoperative pain relief in infants and children. Kinetics of epidural fentanyl.The pharmacokinetics of the effervescent vs. conventional tramadol/paracetamol fixed-dose combination tablet in patients after total gastric resection.Pharmacokinetics of sufentanil administered with 0.2% ropivacaine as a continuous epidural infusion for postoperative pain relief in infants.Pharmacokinetic Studies of Oxathio-Heterocycle Fused Chalcones.Effects of Low-Dose Escherichia coli Lipopolysaccharide-Induced Endotoxemia on Morphine Pharmacokinetics in an Animal Model.Withdrawal of cefoperazone with milk after intramammary administration in dairy cows - prospective and retrospective analysis.Metal ion-oxytetracycline pharmacokinetic interactions after oral co-administration in broiler chickens.Classification model of amino acid sequences prone to aggregation of therapeutic proteins.Pharmacokinetics of flunixin in mature heifers following multiple intravenous administration.Chromatographic/mass spectrometric method for the estimation of itraconazole and its metabolite in human plasma. Application to a bioequivalence study.Pharmacokinetics and pharmacodynamics of propofol during propofol-alfentanil and propofol-remifentanil total intravenous anaesthesia monitored by spectral frequency index.Pharmacokinetics of orally administered simvastatin in turkeys.Bioavailability of veterinary drugs in vivo and in silico.Pharmacokinetic investigations of the marker active metabolites 4-methylamino-antipyrine and 4-amino-antipyrine after intramuscular injection of metamizole in healthy piglets.C (max) and t (max) verification using Fibonacci sequence and absorption rate.Metronidazole pharmacokinetics during rapid growth in turkeys - relation to changes in haemodynamics and drug metabolism.Correlation between in silico physicochemical characteristics of drugs and their mean residence time in human and dog.Pharmacokinetics of sunitinib in combination with fluoroquinolones in rabbit model.Synthesis, physicochemical and pharmacokinetic characterization of calcium uronates.The influence of rapid growth on sodium salicylate pharmacokinetics in male turkeys.The penetration of sunitinib through the blood-brain barrier after the administration of ciprofloxacin.Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.The influence of the time-of-day administration of sunitinib on the penetration through the blood-brain and blood-aqueous humour barriers in rabbits.The concomitant use of lapatinib and paracetamol - the risk of interaction.Quercetin decrease somatic cells count in mastitis of dairy cows.The influence of a single and chronic administration of venlafaxine on tramadol pharmacokinetics in a rabbit model.Pharmacokinetic drug-drug interaction between erlotinib and paracetamol: A potential risk for clinical practice.The pharmacokinetics of oral ketoprofen in patients after gastric resection.The influence of rapid growth in broilers on florfenicol pharmacokinetics - allometric modelling of the pharmacokinetic and haemodynamic parameters.Correlation of elimination fraction area under the curve with total body clearance.Evaluation of sampling spacing in pharmacokinetic studies using six sigma method.Sampling intervals verification in pharmacokinetics studies.
P50
Q28546523-46B7A5D7-940A-41BD-980E-C4BD42B86D97Q33486924-97B45062-1F51-4750-8E10-4778EF3D8BF2Q33811849-DCB82A9E-5E31-4032-87C9-CDB079958FEDQ34777859-749BB8FA-C98B-4A70-B2DB-6018A8086E5EQ35589195-B9EFF7D9-170D-4055-9485-08EE9F6D7D20Q36203571-30A2FE6C-4181-49E8-8E9B-4C03B7848123Q37990966-B19B8A17-FC52-4CAE-9460-212C4673F64BQ39190328-9963C237-9F8D-4F2B-8EB2-ABFF3F9C628CQ39205875-858A0D03-5324-483C-A163-4918C16FFF99Q39207161-8E4C299E-4DFC-4053-9C21-40468B285AB2Q40055852-67E2719A-5621-41F6-9CF1-2644CF2DAD61Q40057969-43E7A2B9-FC6A-4430-8D66-966CD64FBE8EQ40069831-5A514E1D-719D-49C5-970B-9CDA404D4983Q40670629-B8721DBB-B2DE-4E1A-A829-8F0B894F9611Q42428682-5023CA88-944D-4B04-9747-BB0D16868D20Q42600982-6D69D620-CA69-43B4-81D3-C47A98E7B7FDQ43265191-97A1BEA5-9382-4830-A6E8-3C4474820A86Q43269487-D282F3DE-6DF3-4EF1-8634-1448C50F2AFAQ44711503-86F6BBE5-9BDE-44FC-837D-C0DB37F0DD17Q45349568-9290B353-9D9A-469A-A22A-FA1B518F81ACQ46466399-2007DDD6-21D5-4D0E-81F1-87F054733E92Q46584094-133A7A77-F94E-4BC5-88E5-05F25B21B535Q46604522-44CD8E39-5CA5-4C9A-A2D3-81613D98269CQ46621575-4C557C55-E37A-46D0-A1D9-50B433119231Q46766548-4566E296-9626-47E3-8CDD-EB28D1CDC372Q46858841-CF257616-94D5-42C3-82BD-FBC9E394EE56Q48197018-BB5904B9-C6F2-45B7-B11B-7ADD341FB5BBQ48502482-9C06F883-55B4-4250-AAEB-3EFFE07333C6Q48591377-19F78CCD-61AC-4DE9-8F15-E63EEC9092EAQ48676307-C2187B0E-39EB-4BD5-956A-F2FF2A6636EBQ48947779-E3A4DE41-62D8-46B6-9C11-8E9534D7C90CQ49722102-A2AD4798-3886-4D6E-A18D-8C3581A1779EQ50054728-1BA3154C-D19F-48DE-A855-65EC3882898FQ50759666-EB034D31-ACE1-48B5-9F9F-1F54B7C57AB4Q50876022-0177E33C-900E-4FA3-90E9-8136B6BFD86FQ50904196-9641AED2-AFB3-4077-8077-6E1DA5C652A8Q50930805-AA5C408D-A6FE-46A9-9656-417CEA1E623EQ51025681-AAFF9210-1E3F-472B-92F2-B13C52905EB5Q51075358-A6A2F700-2C87-4D61-B7A1-3083585ADAE4Q51134152-5A1CCCEF-B86A-4553-AB4C-4E93DF281F76
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Tomasz Grabowski
@ast
Tomasz Grabowski
@en
Tomasz Grabowski
@es
Tomasz Grabowski
@nl
Tomasz Grabowski
@sl
type
label
Tomasz Grabowski
@ast
Tomasz Grabowski
@en
Tomasz Grabowski
@es
Tomasz Grabowski
@nl
Tomasz Grabowski
@sl
prefLabel
Tomasz Grabowski
@ast
Tomasz Grabowski
@en
Tomasz Grabowski
@es
Tomasz Grabowski
@nl
Tomasz Grabowski
@sl
P106
P21
P214
142147266645135481001
P31
P496
0000-0002-3077-9698
P734
P735
P7859
viaf-142147266645135481001